Anapharm Bioanalytics is a European specialized bioanalytical CRO supporting innovative biotechnology and pharmaceutical companies from preclinical development to clinical studies. The company provides high-quality bioanalysis and bioanalytical services for small molecules and biologics, with expertise in LC-MS/MS, ligand-binding assays (ELISA and MSD) and cell-based assays. Anapharm supports preclinical and clinical programmes with services including pharmacokinetics (PK), immunogenicity (ADA/NAb), pharmacodynamics (PD) and biomarker analysis. The organisation combines strong scientific and regulatory expertise with a flexible and collaborative approach particularly suited for early-stage and innovation-driven companies requiring responsive project management and tailored scientific support. Anapharm Bioanalytics operates internationally with a strong European focus and extensive experience supporting innovative drug development programmes.